Stero Biotechs, an Israel-based, clinical-stage company focused on Cannabidiol (CBD) formulation research and development, in a collaboration with its main partner and shareholder, Mor Research Applications, the Tech Transfer Office (TTO) of the largest Health Maintenance Organiztaion (HMO) in Israel – Clalit, announced today a new clinical trial in the global efforts of fighting the COVID-19 virus.
April 20, 2020
· 2 min read